Search Results - robert+modlin

3 Results

Sort By:

CD1a Presentation of Microbial Peptide Antigens to T Cells (UCLA Case No. 2026-067)

Contact UCLA Technology Development Group to learn more. More information available soon.

Published: 10/1/2025 | Inventor(s): Robert Modlin

Keywords(s):

Category(s): Therapeutics > Dermatology

2019-694 ROLE OF BACTERIAL RNA IN INFLAMMATION IN ACNE

SUMMARY:UCLA researchers in the Department of Dermatology have developed a new treatment for acne that can effectively alleviate the inflammatory response caused by acne-inducing bacteria. BACKGROUND:Acne is a chronic skin disease that was estimated to affect 633 million people globally in 2015, ranking as the 8th most common disease in the world....

Published: 7/17/2025 | Inventor(s): Robert Modlin

Keywords(s):

Category(s): Therapeutics > Dermatology, Therapeutics > Autoimmune, Therapeutics > Inflammation And Inflammatory Diseases

Polycytotoxic T Cells

Case 2016-676UCLA researchers in the Department of Dermatology have characterized a novel subset of CD8+ T cells, termed polycytotoxic, that mediate killing of intracellular pathogens.BACKGROUNDCD8+ T cells are known to engage in cytotoxic activity, where they use pore-forming proteins and proteases (granzyme B, granulysin, and perforin) to induce apoptosis...

Published: 7/17/2025 | Inventor(s): Robert Modlin, Matteo Pellegrini, Samuel Balin, Steffen Stenger

Keywords(s): Autoimmune, Immunology, Infectious Diseases, Life Science Research Tools, Therapeutics & Vaccines

Category(s): Life Science Research Tools, Therapeutics, Diagnostic Markers > Immunology, Therapeutics > Autoimmune, Therapeutics > Infectious Diseases